• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MYX
Click for more information
6.07% $4.18

MAYNE PHARMA GROUP LIMITED - Charts / Financials

Market Cap $393.8M  ! watchlist Created with Sketch. Add to my watchlist

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 21/11/2024 (20 minute delay) ?
Day
Open $4.42   Day High $4.46   Day Low $4.02
Daily Volume 526385
Bids   Sellers
Number Price Volume   Number Price Volume
1 $4.18 1692   1 $4.25 537

Directors & Senior Management

Mr. Shawn Patrick O' Brien Chief Executive Officer, Managing Director, Executive Director
Mr. Aaron Gray Chief Financial Officer
Ms. Laura Loftus Company Secretary
Mr. Frank C. Condella Non-Executive Independent Chairman of the Board
Ms. Anne Nicole Lockwood Non-Executive Director
Mr. David Petrie Non-Executive Director
Mr. Patrick J. Blake Independent Non-Executive Director
Ms. Ann Custin Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
$4.18 		Change
-0.270(6.07%) 		Mkt cap ! $393.8M
Open High Low Value Volume
$4.42 $4.46 $4.02 $2.193M 526.3K

Buyers (Bids)

No. Vol. Price($)
1 1692 $4.18
 

Sellers (Offers)

Price($) Vol. No.
$4.25 537 1
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
Last
$4.26 		  Change
-0.270 ( 4.63 %)
Open High Low Volume
$4.43 $4.45 $4.03 84357
Last updated 15.59pm 21/11/2024 ?

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.